- Report
- October 2021
- 101 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- March 2021
- 45 Pages
Global
From €2408EUR$2,495USD£2,066GBP
- Report
- February 2020
- 137 Pages
Global
From €7717EUR$7,995USD£6,619GBP
- Report
- June 2021
- 75 Pages
Global
€21234EUR$22,000USD£18,215GBP
- Report
- August 2018
- 679 Pages
Global
From €21234EUR$22,000USD£18,215GBP
- Report
- April 2022
- 188 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- April 2022
- 85 Pages
Asia Pacific
From €1448EUR$1,500USD£1,242GBP
- Report
- April 2022
- 85 Pages
Europe
From €1448EUR$1,500USD£1,242GBP
- Report
- April 2022
- 76 Pages
North America
From €1448EUR$1,500USD£1,242GBP
- Report
- March 2023
- 33 Pages
Global
From €1882EUR$1,950USD£1,614GBP
- Report
- October 2018
- 50 Pages
Global
From €8199EUR$8,495USD£7,033GBP
- Report
- September 2018
- 101 Pages
Global
From €6177EUR$6,400USD£5,299GBP
- Report
- September 2018
- 159 Pages
Global
From €5791EUR$6,000USD£4,968GBP
- Report
- March 2022
- 81 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- March 2020
- 118 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- February 2024
- 176 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- February 2024
- 187 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- September 2023
- 160 Pages
Global
From €2895EUR$2,999USD£2,483GBP
- Report
- May 2023
- 160 Pages
Global
From €5790EUR$5,999USD£4,967GBP
- Book
- September 2010
- 544 Pages
Crohn's Disease is a chronic inflammatory condition of the gastrointestinal tract, primarily affecting the small and large intestine. It is a type of Inflammatory Bowel Disease (IBD) and is characterized by abdominal pain, diarrhea, fatigue, weight loss, and malnutrition. Symptoms can range from mild to severe and can be managed with medications, lifestyle changes, and in some cases, surgery.
The Crohn's Disease market within the context of Gastroenterology is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global market for Crohn's Disease treatments will reach $7.5 billion by 2027. The market is driven by the increasing prevalence of the disease, the development of new treatments, and the growing awareness of the condition.
Companies in the Crohn's Disease market include AbbVie, Pfizer, Janssen, Takeda, and Celgene. These companies are involved in the development and marketing of treatments for Crohn's Disease, including biologics, small molecules, and other therapies. Show Less Read more